Evaluation of the reliability, usability, and applicability of AMSTAR, AMSTAR 2, and ROBIS: protocol for a descriptive analytic study
暂无分享,去创建一个
A. Gates | M. Gates | G. Duarte | M. Cary | Monika Becker | B. Prediger | B. Vandermeer | R. Fernandes | D. Pieper | L. Hartling
[1] B. Everitt,et al. Statistical methods for rates and proportions , 1973 .
[2] J. Fleiss,et al. Statistical methods for rates and proportions , 1973 .
[3] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[4] T. Chalmers,et al. Meta-analyses of randomized controlled trials. , 1987, The New England journal of medicine.
[5] A. Feinstein,et al. High agreement but low kappa: I. The problems of two paradoxes. , 1990, Journal of clinical epidemiology.
[6] D. Moher,et al. Statistical power, sample size, and their reporting in randomized controlled trials. , 1994, JAMA.
[7] S. Golder,et al. The effectiveness and cost-effectiveness of prophylactic removal of wisdom teeth. , 2000, Health technology assessment.
[8] A J Sutton,et al. Publication and related biases. , 2000, Health technology assessment.
[9] David Moher,et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews , 2007, BMC medical research methodology.
[10] K. Gwet. Computing inter-rater reliability and its variance in the presence of high agreement. , 2008, The British journal of mathematical and statistical psychology.
[11] David Moher,et al. Assessing the Quality of Reports of Systematic Reviews: The QUOROM Statement Compared to Other Tools , 2008 .
[12] David Moher,et al. Non-Cochrane vs. Cochrane reviews were twice as likely to have positive conclusion statements: cross-sectional study. , 2009, Journal of clinical epidemiology.
[13] Jeremy Grimshaw,et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. , 2009, Journal of clinical epidemiology.
[14] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.
[15] E. Tacconelli. Systematic reviews: CRD's guidance for undertaking reviews in health care , 2010 .
[16] C. Teng,et al. Interpreting systematic reviews: are we ready to make our own conclusions? A cross-sectional study , 2011, BMC medicine.
[17] J. Higgins. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .
[18] Yuxia Wu,et al. Reliability and External Validity of AMSTAR in Assessing Quality of TCM Systematic Reviews , 2012, Evidence-based complementary and alternative medicine : eCAM.
[19] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[20] Denise Thomson,et al. A Descriptive Analysis of Overviews of Reviews Published between 2000 and 2011 , 2012, PloS one.
[21] Kehu Yang,et al. Quality and transparency of overviews of systematic reviews , 2012, Journal of evidence-based medicine.
[22] Dawid Pieper,et al. Overviews of reviews often have limited rigor: a systematic review. , 2012, Journal of clinical epidemiology.
[23] Lisa Hartling,et al. Testing the risk of bias tool showed low reliability between individual reviewers and across consensus assessments of reviewer pairs. , 2013, Journal of clinical epidemiology.
[24] J. Higgins,et al. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration , 2013 .
[25] B. Prediger,et al. Systematic review found AMSTAR, but not R(evised)-AMSTAR, to have good measurement properties. , 2015, Journal of clinical epidemiology.
[26] P. Shekelle,et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation , 2015, BMJ : British Medical Journal.
[27] P. Shekelle,et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement , 2015, Systematic Reviews.
[28] David Moher,et al. Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional Study , 2016, PLoS medicine.
[29] Lisa Hartling,et al. What guidance is available for researchers conducting overviews of reviews of healthcare interventions? A scoping review and qualitative metasummary , 2016, Systematic Reviews.
[30] Rachel Churchill,et al. ROBIS: A new tool to assess risk of bias in systematic reviews was developed , 2016, Journal of clinical epidemiology.
[31] P. Shekelle,et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation , 2016, British Medical Journal.
[32] N. Gogtay,et al. Measures of Association. , 2016, The Journal of the Association of Physicians of India.
[33] Philippe Ravaud,et al. Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer , 2016, BMC Medicine.
[34] R. Fernandes,et al. Evaluation of AMSTAR to assess the methodological quality of systematic reviews in overviews of reviews of healthcare interventions , 2017, BMC Medical Research Methodology.
[35] D. Pieper,et al. The risk of bias in systematic reviews tool showed fair reliability and good construct validity. , 2017, Journal of clinical epidemiology.
[36] D. Pieper,et al. Inter-rater reliability of AMSTAR is dependent on the pair of reviewers , 2017, BMC Medical Research Methodology.
[37] Paul Montgomery,et al. Risk of bias in overviews of reviews: a scoping review of methodological guidance and four‐item checklist , 2017, Research synthesis methods.
[38] R. Churchill,et al. An overview of systematic reviews of complementary and alternative therapies for fibromyalgia using both AMSTAR and ROBIS as quality assessment tools , 2017, Systematic Reviews.
[39] P. Tugwell,et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both , 2017, British Medical Journal.
[40] M. Capobussi,et al. Quality assessment versus risk of bias in systematic reviews: AMSTAR and ROBIS had similar reliability but differed in their construct and applicability. , 2018, Journal of clinical epidemiology.